Way-out artistocrat who drilled a hole in her own head started a healthcare revolution worth £58M dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission.
United Kingdom-based startup Beckley Psytech is gearing up for a Phase 1 clinical trial investigating a synthetic version of 5-MeO-DMT. The trial is looking at the benefits of this unique psychedelic as a treatment of neuropsychiatric diseases.
5-MeO-DMT is an unlikely psychedelic compound. It’s not a plant or fungus it’s excreted through the skin of the Sonoran Desert toad. Chemically similar to DMT, 5-MeO-DMT is fast-acting with a short duration. Researchers believe its mind-altering effects could offer benefits similar to other psychedelic drugs such as psilocybin, especially when combined with psychotherapy.